Celltrion
068270.KS
₹9,762
Share price
-1.89%
Change (1 day)
-11.02%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
EPS for Celltrion (068270.KS)
EPS in 2023 (TTM): ₹245.26
According to Celltrion 's latest financial reports the company's current EPS (TTM) is ₹257.27. In 2022 the company made an earnings per share (EPS) of ₹250.46 a decrease over its 2021 EPS that were of ₹297.60.
EPS history for Celltrion from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | ₹245.26 | -2.07% |
| 2022 | ₹250.46 | -15.84% |
| 2021 | ₹297.60 | 12.77% |
| 2020 | ₹263.89 | 70.79% |
| 2019 | ₹154.51 | 15.63% |
| 2018 | ₹133.63 | -33.13% |
| 2017 | ₹199.84 | 141.17% |
| 2016 | ₹82.87 | 8.28% |
| 2015 | ₹76.53 | 11.28% |
| 2014 | ₹68.77 | 16.37% |
| 2013 | ₹59.10 | -67.42% |
| 2012 | ₹181.41 | 84.22% |
| 2011 | ₹98.48 | 62.13% |
| 2010 | ₹60.74 | 80.61% |
| 2009 | ₹33.63 | -559.63% |
| 2008 | -₹7.32 | -123.16% |
| 2007 | ₹31.59 |